Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
AMEX
$0.88-4.23%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 88,680
- 52-week high
- —
- 52-week low
- —
- Open
- $0.90
- Day high
- $0.90
- Day low
- $0.88
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $90K | -$33.89M | -$1.09 |
| 2024 | — | -$38.24M | -$1.27 |
| 2023 | $81K | -$48.82M | -$1.83 |
| 2022 | $1.03M | -$33.02M | -$1.37 |
| 2021 | $1.14M | -$24.77M | -$1.20 |
About Actinium Pharmaceuticals, Inc. (Delaware)
A company overview for Actinium Pharmaceuticals, Inc. (Delaware) is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Actinium Pharmaceuticals, Inc. (Delaware)'s stock price today?
- ATNM is trading at $0.88 as of Jul 20, 2026.
- Does Actinium Pharmaceuticals, Inc. (Delaware) pay a dividend?
- Actinium Pharmaceuticals, Inc. (Delaware) did not pay a dividend in its most recent reported fiscal year.